Vistusertib(AZD2014)

DRUG2 trials

Sponsors

Samsung Medical Center

Conditions

Solid Tumor

Phase 2

Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy

WithdrawnNCT03166904

Samsung Medical CenterSolid Tumor

Start: 2018-03-31End: 2018-07-31Updated: 2019-05-20

Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy

WithdrawnNCT03166176

Samsung Medical CenterSolid Tumor

Start: 2018-03-31End: 2018-07-31Updated: 2019-05-20